Evidence of Artemisinin-Resistant Malaria in Africa | Zendy

Betty Balikagala | Zendy; Naoyuki Fukuda | Zendy; Mie Ikeda | Zendy; Osbert T. Katuro | Zendy; ShinIchiro Tachibana | Zendy; Masato Yamauchi | Zendy; Walter Opio | Zendy; Sakurako Emoto | Zendy; Denis A. Anywar | Zendy; Eisaku Kimura | Zendy; Nirianne Palacpac | Zendy; Emmanuel Igwaro Odongo-Aginya | Zendy; Martin Ogwang | Zendy; Toshihiro Horii | Zendy; Toshihiro Mita | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evidence of Artemisinin-Resistant Malaria in Africa

Author(s) -

Betty Balikagala,

Naoyuki Fukuda,

Mie Ikeda,

Osbert T. Katuro,

ShinIchiro Tachibana,

Masato Yamauchi,

Walter Opio,

Sakurako Emoto,

Denis A. Anywar,

Eisaku Kimura,

Nirianne Palacpac,

Emmanuel Igwaro Odongo-Aginya,

Martin Ogwang,

Toshihiro Horii,

Toshihiro Mita

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2101746

Subject(s) - artemisinin , malaria , virology , plasmodium falciparum , biology , immunology

In the six Southeast Asian countries that make up the Greater Mekong Subregion, Plasmodium falciparum has developed resistance to derivatives of artemisinin, the main component of first-line treatments for malaria. Clinical resistance to artemisinin monotherapy in other global regions, including Africa, would be problematic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research